BluePath Capital Management LLC Raises Stake in The Procter & Gamble Company (NYSE:PG)

BluePath Capital Management LLC increased its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 18.1% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 6,138 shares of the company’s stock after acquiring an additional 939 shares during the quarter. Procter & Gamble comprises 0.7% of BluePath Capital Management LLC’s holdings, making the stock its 28th largest position. BluePath Capital Management LLC’s holdings in Procter & Gamble were worth $1,063,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Itau Unibanco Holding S.A. purchased a new position in shares of Procter & Gamble during the second quarter worth approximately $28,000. Fairway Wealth LLC purchased a new position in Procter & Gamble during the 2nd quarter worth $29,000. Ruedi Wealth Management Inc. raised its position in Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after purchasing an additional 77 shares in the last quarter. POM Investment Strategies LLC purchased a new stake in shares of Procter & Gamble in the 2nd quarter worth $34,000. Finally, Quest Partners LLC bought a new position in shares of Procter & Gamble during the 2nd quarter worth $36,000. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Down 0.0 %

Shares of NYSE PG opened at $165.10 on Friday. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The business’s 50 day moving average is $171.62 and its two-hundred day moving average is $167.91. The Procter & Gamble Company has a 52-week low of $142.50 and a 52-week high of $177.94. The firm has a market cap of $388.82 billion, a price-to-earnings ratio of 28.47, a PEG ratio of 3.59 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. During the same quarter in the previous year, the business posted $1.83 earnings per share. The business’s quarterly revenue was down .6% compared to the same quarter last year. Research analysts predict that The Procter & Gamble Company will post 6.94 EPS for the current year.

Procter & Gamble Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.44%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s dividend payout ratio is currently 69.48%.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CEO Jon R. Moeller sold 37,240 shares of the company’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $168.89, for a total transaction of $6,289,463.60. Following the completion of the sale, the chief executive officer now directly owns 263,537 shares of the company’s stock, valued at $44,508,763.93. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CEO Jon R. Moeller sold 37,240 shares of the firm’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $168.89, for a total value of $6,289,463.60. Following the completion of the sale, the chief executive officer now directly owns 263,537 shares of the company’s stock, valued at $44,508,763.93. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Susan Street Whaley sold 450 shares of the stock in a transaction on Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total value of $76,149.00. Following the completion of the transaction, the insider now owns 13,072 shares of the company’s stock, valued at $2,212,043.84. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 389,144 shares of company stock worth $66,184,385. Insiders own 0.18% of the company’s stock.

Analyst Ratings Changes

PG has been the subject of several recent research reports. Stifel Nicolaus lifted their price objective on Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a report on Monday, July 22nd. StockNews.com cut shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Royal Bank of Canada reissued a “sector perform” rating and set a $164.00 price objective on shares of Procter & Gamble in a report on Monday, October 21st. Morgan Stanley upped their target price on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a report on Monday, October 21st. Finally, DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target for the company in a research report on Thursday, August 29th. Nine investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and an average target price of $177.00.

Read Our Latest Report on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.